Manatt’s Jocelyn Guyer, a managing director with Manatt Health, was quoted by Modern Healthcare in an article examining references to the opioid epidemic and drug pricing in President Trump’s State of the Union address.
The publication noted that during his speech, Trump called reducing prescription drug prices one of his greatest priorities, emphasizing that prices will come down. However, industry experts have expressed frustration at the lack of specific policy actions surrounding this promise.
“In the weeks ahead, the key issue to watch is whether his remarks are backed up by a strong push for significant new funding and tools for states and localities to tackle the epidemic,” explained Guyer.
Read the article here.